Eos Advisory: Investment Portfolio & Startup News
Eos Advisory
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
TaiSan raises £4.7m in funding led by Eos Advisory and Mercia Ventures for solid-state sodium-ion batteries
TaiSan develops solid-state sodium-ion batteries that are lighter and more compact than existing sodium-ion and lithium-ion alternatives. Its technology is designed for applications such as electric bikes, scooters, vehicles and power tools, offering longer service life and greater safety than conventional flammable liquid electrolytes.
Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
Scarlet Therapeutics develops engineered red blood cells designed to treat metabolic diseases and address shortages in rare blood supplies. Scarlet Therapeutics uses synthetic biology and proprietary cell line technology to create lab-grown red blood cells that can be manufactured at scale for therapeutic and transfusion use.
EnsiliTech raises £4.5m seed round led by Eos Advisory to transform global medicine storage and transport
EnsiliTech develops technology that stabilises vaccines and biologics at high temperatures, removing the need for cold-chain storage and improving global access to medicines.
Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies
Laverock Therapeutics is developing programmable gene control technologies that enable advanced therapies to respond dynamically to disease, improving precision, safety and effectiveness in cell-based treatments.
Concinnity Genetics raises £3m seed round led by Eos Advisory to establish RNA-based gene therapy control systems
Concinnity Genetics develops RNA based control systems that allow gene and cell therapies to be adjusted after dosing, improving safety and flexibility in advanced medical treatments.
Naturbeads lands £8m Series A led by EOS to tackle microplastic pollution with sustainable cellulose microspheres
Naturbeads produces biodegradable cellulose microspheres that replace microplastics in everyday products, enabling manufacturers to meet regulatory requirements without compromising performance.
More venture news
- 26 Oct 2026
NousNous raises £13m in funding led by Heartcore Capital and Mosaic Ventures for an AI agent that manages household bills and admin
EquityConsumer - 19 Oct 2026
FrugaFruga secures a £1m in funding led by PXN Ventures to lower insurance renewal premiums through open banking
EquityFintech - 13 Oct 2026
SainapticSainaptic raises £1m in funding led by Cornerstone VC and Ufi Ventures for AI-assisted marking of vocational and professional qualifications
EquityEducation
